10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What is the variability in left ventricular ejection fraction (LVEF) as measured by different cardiac imaging modalities?

          Findings

          In this multicenter diagnostic study of 2032 patients with coronary artery disease and LVEF of 35% or less with imaging interpreted by core laboratories, correlation of LVEF between modalities ranged from r = 0.493 (for biplane echocardiography and cardiovascular magnetic resonance) to r = 0.660 (for cardiovascular magnetic resonance and gated single-photon emission computed tomography). There was no systematic overestimation or underestimation of LVEF for any modality.

          Meaning

          There is substantial variability in LVEF assessment between modalities, which should be considered in trial design and clinical management.

          Abstract

          Importance

          Clinical decisions are frequently based on measurement of left ventricular ejection fraction (LVEF). Limited information exists regarding inconsistencies in LVEF measurements when determined by various imaging modalities and the potential impact of such variability.

          Objective

          To determine the intermodality variability of LVEF measured by echocardiography, gated single-photon emission computed tomography (SPECT), and cardiovascular magnetic resonance (CMR) in patients with left ventricular dysfunction.

          Design, Setting, and Participants

          International multicenter diagnostic study with LVEF imaging performed at 127 clinical sites in 26 countries from July 24, 2002, to May 5, 2007, and measured by core laboratories. Secondary study of clinical diagnostic measurements of LVEF in the Surgical Treatment for Ischemic Heart Failure (STICH), a randomized trial to identify the optimal treatment strategy for patients with LVEF of 35% or less and coronary artery disease. Data analysis was conducted from March 19, 2016, to May 29, 2018.

          Main Outcomes and Measures

          At baseline, most patients had an echocardiogram and subsets of patients underwent SPECT and/or CMR. Left ventricular ejection fraction was measured by a core laboratory for each modality independent of the results of other modalities, and measurements were compared among imaging methods using correlation, Bland-Altman plots, and coverage probability methods. Association of LVEF by each method and death was assessed.

          Results

          A total of 2032 patients (mean [SD] age, 60.9 [9.6] years; 1759 [86.6%] male) with baseline LVEF data were included. Correlation of LVEF between modalities was r = 0.601 (for biplane echocardiography and SPECT [n = 385]), r = 0.493 (for biplane echocardiography and CMR [n = 204]), and r = 0.660 (for CMR and SPECT [n = 134]). Bland-Altman plots showed only moderate agreement in LVEF measurements from all 3 core laboratories with no substantial overestimation or underestimation of LVEF by any modality. The percentage of observations that fell within a range of 5% ranged from 43% to 54% between different imaging modalities.

          Conclusions and Relevance

          In this international multicenter study of patients with coronary artery disease and reduced LVEF, there was substantial variation between modalities in LVEF determination by core laboratories. This variability should be considered in clinical management and trial design.

          Trial Registration

          Clinicaltrials.gov Identifier: NCT00023595

          Abstract

          This multicenter diagnostic study determines the intermodality variability of left ventricular ejection fraction (LVEF) measured by echocardiography, gated single-photon emission computed tomography (SPECT), and cardiovascular magnetic resonance (CMR) in patients with coronary artery disease and left ventricular dysfunction.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

          New England Journal of Medicine, 327(10), 685-691
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.

            The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with medical therapy alone, in patients with coronary artery disease, heart failure, and severe left ventricular systolic dysfunction remains unclear.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                31 August 2018
                August 2018
                31 August 2018
                : 1
                : 4
                : e181456
                Affiliations
                [1 ]Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
                [2 ]Duke Clinical Research Institute, Durham, North Carolina
                [3 ]Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
                [4 ]Department of Medicine, Loma Linda University, Loma Linda, California
                [5 ]Department of Cardiology, Loma Linda University, Loma Linda, California
                [6 ]Department of Medicine, Riverside School of Medicine, University of California, Riverside
                [7 ]Department of Cardiology, Riverside School of Medicine, University of California, Riverside
                [8 ]Westchester Medical Center, New York Medical College, Valhalla
                [9 ]Cedars-Sinai Medical Center, Los Angeles, California
                [10 ]Department of Cardiology, St Vincent’s Hospital, University of Melbourne, Melbourne, Australia
                [11 ]Department of Medicine, St Vincent’s Hospital, University of Melbourne, Melbourne, Australia
                [12 ]Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC
                [13 ]Division of Nuclear Medicine, Department of Radiology, Duke University School of Medicine, Durham, North Carolina
                [14 ]Division of Cardiology, Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina
                [15 ]Cardiology Section, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas
                [16 ]Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, North Carolina
                [17 ]Division of Magnetic Resonance Imaging, Silesian Center for Heart Diseases, Zabrze, Poland
                [18 ]Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
                Author notes
                Article Information
                Accepted for Publication: May 30, 2018.
                Published: August 31, 2018. doi:10.1001/jamanetworkopen.2018.1456
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2018 Pellikka PA et al. JAMA Network Open.
                Corresponding Author: Patricia A. Pellikka, MD, Department of Cardiovascular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 ( pellikka.patricia@ 123456mayo.edu ).
                Author Contributions: Dr Pellikka had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Pellikka, Holly, Varadarajan, Panza, Berman, Asch, Desvigne-Nickens, Velazquez, Oh.
                Acquisition, analysis, or interpretation of data: Pellikka, She, Holly, Lin, Pai, Bonow, Pohost, Panza, Berman, Prior, Borges-Neto, Grayburn, Al-Khalidi, Miszalski-Jamka, Desvigne-Nickens, Lee, Velazquez, Oh.
                Drafting of the manuscript: Pellikka, She, Holly, Varadarajan, Pohost, Panza, Borges-Neto, Lee.
                Critical revision of the manuscript for important intellectual content: Holly, Lin, Varadarajan, Pai, Bonow, Pohost, Panza, Berman, Prior, Asch, Grayburn, Al-Khalidi, Miszalski-Jamka, Desvigne-Nickens, Lee, Velazquez, Oh.
                Statistical analysis: She, Al-Khalidi, Lee.
                Obtained funding: Lee, Velazquez, Oh.
                Administrative, technical, or material support: Pellikka, Bonow, Pohost, Panza, Prior, Borges-Neto, Grayburn, Desvigne-Nickens, Oh.
                Supervision: Grayburn, Al-Khalidi, Velazquez, Oh.
                Conflict of Interest Disclosures: Drs She, Panza, and Lee reported grants from the National Heart, Lung, and Blood Institute during the conduct of the study. Dr Berman reported grants from the National Heart, Lung, and Blood Institute during the conduct of the study and personal fees from Cedars-Sinai Medical Center outside the submitted work. Dr Prior reported grants from the National Institutes of Health during the conduct of the study; and personal fees from Novartis and nonfinancial support from Bayer outside the submitted work. Drs Borges-Neto and Al-Khalidi reported grants from Duke University during the conduct of the study. Dr Grayburn reported grants from the National Institutes of Health during the conduct of the study; and grants from Abbott Vascular, Edwards Lifesciences, Medtronic, and Boston Scientific outside the submitted work. Dr Velazquez reported grants from the National Heart, Lung, and Blood Institute during the conduct of the study; and grants and personal fees from Novartis, Philips, and Amgen, grants from Pfizer and Alnylam, personal fees from Merck and Abiomed, and grants from General Electric outside the submitted work. Dr Oh reported grants from the National Institutes of Health during the conduct of the study. No other disclosures were reported.
                Funding/Support: This work was supported by grants U01-HL69015, U01-HL69013, and R01-HL10583 from the National Heart, Lung, and Blood Institute, National Institutes of Health.
                Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Heart, Lung, and Blood Institute.
                Article
                zoi180093
                10.1001/jamanetworkopen.2018.1456
                6324278
                30646130
                508b1546-68a0-48c1-a308-5a58dd485620
                Copyright 2018 Pellikka PA et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 10 March 2018
                : 22 May 2018
                : 30 May 2018
                Categories
                Research
                Original Investigation
                Online Only
                Cardiology

                Comments

                Comment on this article